everolimus
- Product NDC
- 82293-032
- 11-digit product format
- 822930032
- Labeler code
- 82293
- Product ID
- 82293-032_4ca7b927-0d89-0be6-e063-6394a90af200
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- everolimus
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Novugen Pharma (USA) LLC.
- Application
- ANDA219955
- Marketing category
- ANDA
- Marketing start
- 2026-03-30
- Substance
- EVEROLIMUS
- Active strength
- 7.5 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- everolimus
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| EVEROLIMUS | 7.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9HW64Q8G6G |
| Rxcui | 845507, 845515, 998189, 1119400 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 82293-032-10 | 82293003210 | 28 TABLET in 1 BOTTLE (82293-032-10) | 28 tablet | 2026-03-30 | No | No | Current |
| 82293-032-20 | 82293003220 | 7 in 1 BLISTER PACK | | | | | Historical |
| 82293-032-21 | 82293003221 | 4 BLISTER PACK in 1 CARTON (82293-032-21) / 7 TABLET in 1 BLISTER PACK (82293-032-20) | 4 blister pack | 2026-03-30 | No | No | Current |
| 82293-032-30 | 82293003230 | 10 in 1 BLISTER PACK | | | | | Historical |
| 82293-032-31 | 82293003231 | 1 POUCH in 1 CARTON (82293-032-31) / 3 BLISTER PACK in 1 POUCH / 10 TABLET in 1 BLISTER PACK (82293-032-30) | 1 pouch | 2026-03-30 | No | No | Current |